Co-Diagnostics, Inc. Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent
Co-Diagnostics, Inc. (CODX) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent of -1.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent · last filed 2026-03-31
- Co-Diagnostics, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, percent for fiscal 2025 was -1.20%.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, percent for fiscal 2024 was -2.00%.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, percent for fiscal 2023 was -3.50%, a 197.22% decline from fiscal 2022.
- Co-Diagnostics, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, percent for fiscal 2022 was 3.60%, a 1700.00% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.20% 10-K · filed 2026-03-31 | |
| 2024-12-31 | -2.00% 10-K · filed 2026-03-31 | |
| 2023-12-31 | -3.50% 10-K · filed 2025-03-27 | 3.50% 10-K · filed 2024-03-14 |
| 2022-12-31 | 3.60% 10-K · filed 2024-03-14 | -3.60% 10-K · filed 2023-03-16 |
| 2021-12-31 | 0.20% 10-K · filed 2023-03-16 | |
| 2020-12-31 | -8.80% 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |